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Fibroblasts isolated from normal skin, normal scar, 
and hypertrophic scar tissues were compared with re-
spect to their growth curves, protein contents, and abil-
ities to synthesize glycosaminoglycans (GAGs). While no 
significant differences ~ere fou~d wi_th respect ~o p_ro-
tein content or populatiOn doubhng times, we d1d fmd 
significant differences in the proportions of radiolabel 
·ncorporated into the various GAGs among the 3 groups ~f cell lines. Using a dual-label technique t~ label both 
hyaluronic acid and the sulfated GAGs, we Jsola~ed la-
beled constituents from the extracellular, the pencellu-
lar, and the cellular fractions by pronase digestion and 
gel filtration and ide~tifie.d th~ vari.ous GAGs by elec-
trophoresis and selective d1gestwn wtth enzy_mes. Of the 
GAGs isolated from the extracellular fractiOn; hyper-
t rophic scar fibroblasts incorporated pr~portwnately 
more 358 into chondroitin sulfate and less mto heparan 
s ulfate and more ['1H]glucosamine into hyaluro'!ic acid 
than did normal skin fibroblasts. Of the GAGs Isolated 
from the cellular fraction , hypertrophic scar fibroblasts 
incorporated proportionate ly more 358 into heparin and 
less into dermatan sulfate and more [3J:I]gl~cosamine 
into hyaluronic acid than did normal skm fibroblasts. 
These differences in biosynthesis may help to explain 
the differences in GAG content in skin and scars found 
in vivo and to give insight into the development of 
hypertrophic scars. 
The glycosaminoglycan (GAG) content of t he extracellular 
rnatrix of hypertrophic scars (H Sc) differ from thos~ of normal 
scars (NSc). Shetlar eta! [1] reported that chondro1tm sulfate 
(CS) was present as a higher percentage and dermatan sulfate 
(DS) was present as a lower percentage of t he total in HSc 
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t issue compa red to NSc, a nd that NSc contained a lower 
percentage of hyaluronic acid (HA) t han either normal skin 
(NSk) or HSc. In studies using histo logic techniques, Alexander 
and Oonoff [2] observed that OS was sign ficantly reduced in 
areas from HSc that conta ined whorled collagen compared to 
t he collagen with a more normal parallel arrangement. 
In another study [3], HSc tissue was found to contain more 
sul fated GAGs and HA (expressed as mg/tissue dry wt) t han 
NSc. There was both a higher content of HA in t he t issue and 
t he HA represented a greate r percentage of t he total GAGs in 
H Sc compared to NSc. In the case of t he OS, t he HSc contained 
a higher content than NSc, but in each case t he OS represented 
a similar percentage of t he total GAGs. Thus, t here appea r to 
be differences in the GAG content of scar t issue compared to 
normal skin and there also appear to be differe nces in the 
different types of scar t issues. 
The objective of t his study was to determine whether t he 
altered GAG composition of t he extracellular matri x of HSc 
t issue compared to t hat of NSk and NSc tissue is t he result of 
di ffe rences in t he fibrobl asts that synt hesize t he matrices of 
skin and sca r t issues, and also whether t hose differences are 
expressed afte r isolation of t he cells and growth in culture. 
MATERIALS AND METHODS 
Cell Culture 
Human fibroblasts used in th is study were obtained from explant 
culture of human skin and scar t issues removed surgica lly as a pa rt of 
pat ient t reatment. The t issue used to initiate each cell line is described 
in T able I. The cu lt ures were ini tiated in Dulbecco's modified Eagle's 
medium (D MEM ) (Grand Is la nd Biological Co., Grand Is land, New 
York ) plus 10% NuSerum (Collaborative Research Inc., Lex inbrton, 
Massachusetts) supplemented with penicillin and streptomyc in (MA 
Bioproducts, Walkersville, Maryland). The cultu res were weaned from 
the ant ibiotics as early as t he second week of t he explant culture and 
were t hen mainta ined wit hout ant ibiotics. The explant cul tures reached 
confluency at about 4 weeks; they were subsequently split 1:2 or 1:3 
every 5- 7 days or as needed. All t he experiments reported were done 
with early (less than 8 subpassages) cells . 
Growth Cu rve 
The rate of exponentia l population doubling was determined as 
follows. Cells, 1- 5 x 10', were plated into 30-mm culture dishes in 2 
ml DMEM plus 10% NuSerum. Tota l ce ll coun ts per plate were 
determined using a hemocytometer or Coulter particle cou nte r m 
duplicate at 1- to 3-day in terva ls over a 8- to 14 -day period. 
Preparation. of Radiolabeled Proteog/ycan Fractions 
Confluent ce ll cult ures were labeled by incubat ion with DMEM plus 
10% NuSerum supplemented with 5 J.l.Ci I3H] glucosamine (221 mCi/ 
mmol, New England Nuclear, Inc. , Boston, Massachusetts) and 10- 20 
J.l.Ci Na2 ""SO, (775 mCi/ mmol, New England Nuclear, lnc.)/ml medium 
for 24 h. Following this labeling period, 3 fraction s of labeled constit-
uents were obta ined: 
1. The extracellular proteoglycans were isolated from the medium. 
The medium was decan ted from the cell laye r and each cu lture rinsed 
(2 X 5 mi n) with cold Hanks' basic sa lt solution (HBSS) (MA Bioprod-
ucts) . The medium and rinses were pooled, cell debris was removed by 
centrifugation, and the supernatant medium fraction (M) was retained 
for further ana lys is. 
2. The pericellular proteoglycans were released from t he cell layer by 
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T ABL E I. The tissue of origin and popu.lation in doubling /;ime for each cell line 
Time since Doubling time Explant source Cell line (h) Age, sex burn 
N ormal skin 
2266 36.90 14 yrs, F Right buttock 14112 yrs 
1901 NO 11 yrs, M Buttocks 3'12 yrs 
1450 37.98 7 yrs, M Thigh 6 yrs 
2659 32.66 20 mos, F Back, periphery NA 
of nevus 
x 35.84 ± 2.30 
Normal scar 
410 34 .51 16 yrs, F Face 2 yrs 
2962 39.27 14 yrs, F Face 13 yrs 
2252 33.69 14 yrs, M Face 2112 yrs 
2532 49.56 9 yrs, M Eyelid 15 mos 
2735 46. 17 7 yrs, F Forearm 7 yrs 
x 40.64 ± 6.29 
Hypertrophic scar 
2356 45.48 7 
2784 36.71 5 
2166 49.43 4 
x 43.87 ± 5.32 
treatment with trypsin (bovin e pronase crystalline, Calbiochem-Behr-
ing Corp., La J olla, Cali fo rnia) for 15 min and 0.1 mg/ml phosphate-
buffered saline that was free of Ca2+ and Mg2+. T he action of the 
enzyme was stopped by the addit ion of excess soybean t rypsin inhibitor 
(Worthington Diagnostic Systems, Inc.). The cells detached by the 
t ryps in treatment were collected by cent ri fugation, rinsed once wit h 
HBSS, and the t rypsin digest and the ce ll rinse fluid were pooled to 
form the tryps inate (T) fraction. 
3. T he remainin g cellular proteoglycans were solubilized by our di -
gesti ng the ce lls in 1 N NaO H at room temperature fo r 1 h. T he 
solution was then neut ralized with HCl to fo rm the cellular (C) fraction. 
Treatment a.nd Analysis of Samples 
Each M, T, and C fraction was dialyzed extensive ly against 0.05 M 
Na2SO,, then water, and was then freeze dried. T he protein contents 
of the C fractions were dete rmined using a Folin -phenol reagent [4]. 
The GAG chai ns were released from the proteoglycans (PGs) by 
degradation of the protein core by pronase (Calbiochem) enzyme 10% 
w/w with sample fo r 48 h (0.15 M NaCl, 5 mM CaCI2, 5 mM T ris- HCl, 
pH 7.5, at 37"C). After the enzyme t reatment, the samples were dialyzed 
against water and freeze dried. 
Gel Filtration Chromatography 
GAG constituents were fractionated on a column (1.5 x 44 em) 
packed with Sepha rose CL-4B (Pharmacia Fine Chemicals, Uppsala, 
Sweden) and eluted with 3 M guanidine hydrochloride. T he column 
was operated at a fl ow of 12 ml / h and 2-ml fractions were collected. 
We analyzed the column fractions by measuring the qua nti ties of 
radioactivity in a li quots (50- 100 11 ll mixed wi th 3.5-ml scint iverse 
Rcinti llation cocktail (Fisher Scient ific) using a Beckman LS-250 scin -
ti llation counter. T he colum n fractions (P1 and P2) were then pooled, 
dialyzed, and freeze dried. Yo, Vi, and K., va lues were calculated as 
previously described [5 ]. 
Analysis of Glycosam inoglycan.s 
T he GAG content of the va rious samples was dete rmined by electro-
phoresis on ce llulose acetate plates according to the method described 
by Cappelletti, Del Rosso, and Chiarugi [6]. T he identity of each band 
was ve ri fied by comparisons with standard GAG samples (1977, refer-
ence Standard Contract #AMS-2205 DHEW -N IH-NTAMDD) as well 
as selective digestion wi th chondroit inase ABC, chondroit inase AC 
(Seikagaku Kogyo Co., Ltd., Tokyo, Japan), hyaluronidase (strepto-
myces), and t reatment wit h ni t rous ac id [7]. The quanti ties of radio-
activity in individual GAG bands were determined by our cutting up 
the plates, using t he mobili ties of the standard GAGs as a guide and, 
after plac ing the plate cut pieces in scinti llation cocktai l, count ing in a 
Beckman LS-250 apparatus. Background counts were determined by 
measuring the radioactivity in the GAG standard ba nds. 
RESU LTS 
Growth Curues 
T he expo ne ntia l doubling t imes fo r t he cell lines used a re 
li sted in Table I. T hree represe ntative gr owth curves a re s hown 
yrs, F Forearm 15 mos 
yrs, M Shoulder 14 mos 
yrs, M Neck 3 yrs 
3 
HOURS 
FIG 1. Growth curves of representative !ibroblast cell lines derived 
from normal skin (e e ), normal scar (.A.- -.A.) and hyper-
t rophic scar t issues (D-----0). Replicate cultures of human fibro-
blasts were seeded at 5 X 104 cells per 30-mm plate in 2 ml DMEM 
supplemented wi th 10% NuSe rum. Each t ime point represents 2 sepa-
rate determinations. 
in Fig 1. There was no significan t differe nce between t h e 
average doubling t imes of th e N S k-, N Sc-, a nd H Sc-derived 
fibroblast cell lines. 
Distribution of Radio/abel Among the Various Fractions 
The distribu t ion s of 3H and a5S a mo ng t he M , T , and C 
fractions are listed in T a ble II . The M fraction contained t h e 
highest p ropor t ion of both 3H a nd :158 a nd t he C fractio n 
con tained t he lowest proport ion o f radiolabeled constitue n ts. 
There was no s ignifica n t difference in t he distribut ion of radi -
ola bel amo ng t he fractions from skin - and scar -de rived cell 
lines. 
Protein Content and Radiolabel Incorporation 
The protein con ten t and radiola bel incorpora t ed into t h e 
medium expressed pe r 104 cells is shown in T able Ill. There 
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TABLE II. Distribution of labeled constituents in medium, trypsinate, and cell residue 
Tissue origi n (N) Medium Trypsinate Ce ll residue 
Percent cpm 3H 
Normal skin 
Normal scar 
Hype rLrophic scar 
6 
7 
4 
73. 15 ± 5.39 
70.93 ± 2.65 
78.79 ± 6.23 
16.23 ± 5.98 10.64 ± 3.79 
16.86 ± 4.16 12.21 ± 2.76 
11.56 ± 3.30 9.65 ± 4.14 
Percent cpm 35SO, 
Normal skin 
Normal scar 
Hypertrophic scar 
6 
7 
4 
67.98 ± 4.05 23. 14 ± 4.24 8.88 ± 2.75 
68.78 ± 2.19 23.64 ± 4.49 7.58 ± 3.28 
69.33 + 5.27 21.82 + 5.12 8.84 + 1.18 
Each fraction was harvested, dialyzed, freeze-dried, and digested with pronase as described in Materials and Methods. Aliquots were taken for 
liquid scintillation coun ting from the pronase solution . The resul ts are given in percent cpm 3H and cpm '15S incorporated into each fraction ± 
SE- N is the number of cell lines tested. 
TABLE III. Quantity of radiolabel incorporated into the medium and 
protein contained by the cells 
11g protein/ 106 ce lls cpm 3H/ l0' cell s cpm ""S/ 10' cells 
NSK 300 ± 82 (5) 1426 ± 791 (5) 329 ± 219 (5) 
NSc 408 ± 72 (3) 1609 ± 1057 (5) 237 ± 78 (5) 
HSc 477 ± 193 (7) 1486 ± 1642 (6) 172 ± 88 (6) 
The medium was harvested, dialyzed, freeze-dried , and digested with 
pronase as described in Materials and Methods. Aliquots were taken 
for liquid scintillation cou nting and the cells were digested w1th NaOH, 
neutralized, a nd a liquots taken fo r protein determination as described 
in Materials and Methods. There was no significant difference in the 
protein content or the amount of 3H or 35S incorporated into macro-
molecules isolated from the medium of fibroblasts from normal sk in , 
norma l scar, or hypertrophic scar. Numbers in parentheses are the 
number of ce ll lines tested. 
was no signifi cant difference between skin - and scar-derived 
fibroblasts with respect to protein content of t he cells or the 
incorpo ration of 3H and '1''8 into the macromolecules of the 
medium. 
Analysis of the GAGs 
Column chromatography: After pronase digestion t he radio-
labeled constituents from each of the fractions , M, T , and C 
from NSk-, NSc-, and HSc-derived fibroblasts, were dialyzed 
extensively and subjected to column chromatography. Repre-
sentative elution profiles are shown in Figs 2, 3, and 4. Two 
peaks were obtained from the medium of.NSk_- •. NSc-, and HSc-
derived fibroblasts. A major peak of radwactivity eluted at the 
Vo (P 1) and a secondary peak of material eluted in the included 
volume (P2) (Fig 2) . The percentage of cpm 3H from the 
medium recovered from Pl was 52± 25.66 for NSk cells, 27 ± 
24.73 for NSc cells, and 62.25 ± 11.58 for HSc cells. 
The profiles of t he (35S]GAGs found in the medium from 
cultures of NSk, NSc, and HSc fibroblasts were very similar 
(Fig 2). The 35S-labeled material eluted as a single symmetrical 
peak (P2) in the included volume. The average Kav values ± 
SE for the NSk, NSc, and HSc cells P2 fractions were 0.700 ± 
0.025, 0.690 ± 0.047, 0.640 ± 0.059, respectively. 
Three peaks of material were obtained from the fractionation 
of the [3H]glucosamine-labeled GAGs from the trypsinate of 
NSk, NSc, and HSc cells (Fig 3). The peak corresponding to 
Pl from the medium that eluted at the Vo was usually reduced 
in the trypsinate compared to that of the medium. P2 which 
eluted in the included volume was relatively more prominent 
in the trypsinate samples. A third peak, P 3, eluting at the 
included volume, was not analyzed further. 
The trypsinate (35S)GAGs eluted as a single peak (P2) in the 
included volume similar to that from the medium (Fig 3). The 
average Kavs ± SE of the trypsinate P2 of NSk, NSc, and HSc 
cells were 0.66 ± 0.045, 0.70 ± 0.037, and 0.70 ± 0.062, respec-
t ively. 
The fractionated cell residue labeled constituents were pooled 
in the same way as described for the medium and trypsinate 
samples (Fig 4). The 3H-labeled material eluting at t he Vo, Pl, 
was usually reduced in the cell residue samples from NSk and 
NSc compared to that from HSc cultures. An included peak of 
A. 
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FIG 2. Column chromatography of extrace llula r GAGs synthesized 
by human skin and scar fibroblasts in vitro. Condit ioned medium from 
normal skin (A), normal scar (B), and hypertrophic scar (C) fibroblasts 
incubated for 24 h in DMEM + 10% NuSerum + 5 I' Ci ["H]glucosamine 
and 10 !LCi 35S per ml was collected, concent rated, and treated with 
pronase. The samples were then chromatographed on Sepharose CL4B 
column (1.5 X 44 em) in 3 M guanidine hydrochloride at a flow of 12 
ml/h. 
material , P2, containing both 3H- and 358-labeled material, was 
also obtained. The 3H-labeled material at t he Vi was not 
analyzed further. The 358-labeled GAGs from the cell residue 
of cultures of NSk, NSc, and HSc cells eluted as a single peak 
in the included volume with a minor shoulder on the right side 
of the peak. The average Kav ± SE of t he P2 from the cell 
residue for NSk, NSc, and HSc were 0.71 ± 0.24, 0.69 ± 0.042, 
and 0.65 ± 0.058, respectively. 
Cellulose acetate electrophoresis: The Pl and P2 fractions 
obtained by gel filtration column chromatography, were ana-
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F' IG 3. Column chromatography of cell surface GAGs synthesized 
by cul tures of fibroblasts isolated from human skin and scar. Fibro-
blasts isolated from normal skin (A) , normal scar (B), and hypertroph ic 
scar (C ) were incubated in DMEM + 10% NuSerum containing 5 11Ci 
[' H] glucosamine and 10 11Ci 35S per ml medium for 24 h. The cells were 
then t rypsinized and the cell surface macromolecules were harvested 
as described in Materials an.d M ethods. The samples were then chro-
matographed on Sepharose CL4B column (1.5 X 44 em) in 3 M guani-
dine hydrochloride at a flow of 12 ml / h. 
TABLE IV . Incorporation. of {3H]glu.cosamine in.to HA by fibroblaBts 
from normal shin, normal scar, an.d hypertrophic scar 
Normal skin Normal scar Hypert rophic scar 
Medium 66.15 ± 8.77 72.99 ± 8.46 78.85 ± 7.68 
(11) (17) (11) 
Trypsinate 27.95 ± 12.89 32.44 ± 14.18 40.37 ± 8.31 
(13) (6) (6) 
Cell 10.69 ± 4.25 14.65 ± 0.29 51.62 ± 6.73 
(5) (4) (7) 
The results are given as the % cpm 3H that migrates by electropho-
resis on cellulose acetate with standard HA and is digestib le with 
HAdase ± SO. Numbers in parentheses are the number of determina-
tions. 
lyzed by ce llulose acetate electrophoresis. The radioactivity in 
each band was determined as described in Materials and Meth-
ods and the distribut ion of cpm "H and :"'S in Pl and P2 
fractions a re found in T ables IV and V. 
For all the samples, the material elut ing at the Vo, Pl, labeled 
almost exclusively with [3H)glucosamine and migrated as a 
single lobular band with the same mobility as the HA reference 
band. Th is band was el iminated with hyaluronidase treatment 
but not with chondroitinase ABC or AC (Fig 5) . It was con-
cluded, therefore, that the material in Pl was HA. 
The material eluting in t he included volume, P2, contained 
a component with a similar mobility to the HA reference band 
Vol. 84, No. 6 
A, p 
2000 
0 
........__ 
........__ 
l I B. P1 P2 P3 -J... f------1 
· ~ ·S: ~ ~ ~ 0.:: ~ 0.:: 
~ ~ 200 
" "" ~ 0 ~ '-) 
~ ~ c, ~ P2 ~ ~ 
ELIJT/ON VOLIJME (ml) 
FIG 4. Column chromatography of the cellular GAGs synthesized 
by human skin and scar fibroblasts in vitro. Fibroblasts isola ted from 
normal skin (A), normal scar (B), and hypertrophic scar (C) were 
incubated in DMEM + 10% NuSerum containing 5 11Ci [3H]glucosa-
mine and 10 11Ci 358 per ml medium for 24 h. T he cells were disrupted 
in 1 N NaOH following trypsination, then handled as described in 
Materials an.d M ethods . The samples were then chromatographed on 
Sepharose CL4B column (1.5 x 44 em) in 3 M guanidine hydrochloride 
at a flow of 12 ml/ h. 
TABLE Y. Distribution. of cpm '15S among the varioUB GAGs 
Normal sk in Normal scar Hypertrophic scar 
Medium 
HP 3.79 ± 2.0 6.40 ± 6.35 11.26 ± 7.56 
DS 14.70 ± 2.0 14.84 ± 8.29 10.33 ± 8.94 
HS 21.84 ± 6.90 13.88 ± 2.88 9.86 ± 6.33 
OS' 27.83 ± 7.49 25.47 ± 4.18 21.68 ± 6.20 
cs 31.49 ± 3.04 38.49 ± 7.07 46.76 ± 6.24 
N 19 19 12 
Trypsin.ate 
HP 11.46 ± 2.36 10.41 ± 5.15 6.12 ± 4.03 
HS 44.69 ± 6.38 52.43 ± 23.15 51.14 ± 6.86 
OS' 12.12 ± 1.01 10.03 ± 3.81 5.79 ± 0.57 
cs 34.39 ± 6.66 27.05 ± 22.01 35.18 ± 7.35 
N 18 6 7 
Cell associated 
HP 3.97 ± 1.21 16.97 ± 14.20 18.48 ± 10.71 
DS 29.97 ± 7.77 5.82 ± 1.12 10.53 ± 4.70 
HS 17.16±2.09 12.62 ± 3.47 13.98 ± 2.46 
DS ' 26.19 ± 0.29 27 .44 ± 12.92 25.53 ± 8.29 
cs 22.8 ± 4.69 37.16 ± 11 .82 33.24 ± 9.38 
N 5 5 7 
The 3 fractions were harvested, dialyzed, freeze-dried; treated with 
pronase, and fractionated by column chromatography. The GAGs were 
separated and identified by electrophoresis on cellulose acetate plates. 
Each band was cut out a nd the radioactivity measured by liquid 
scin tillation as described in Materials an.d Methods. The results are 
given as % cpm 358 migrating with standard GAGs ± SE. N = number 
of determinations. 
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FIG 5. Selective enzymatic digestion of Pl isolated from the condi-
tioned medium of normal scar fibroblasts. Normal scar fibr?blasts were 
incubated in DMEM + 10% NuSerum for 24 h. Pl was osolated and 
electrophoresed as described in Materials and Methods. Pl was treated 
with the fo llowing enzymes for 24 h at 3TC: lane I, untreated; lane 2, 
streptomyces hyaluronidase; lane 3, chondroitinase AC; lane 4, chon-
droitinase ABC; lane 5, standard GAGs, heparin (HP), dermatan 
sulfate (DS), heparan sulfate (HS), hyaluronic acid (HA/DS') (also 
indicates where DS' migrated) and chondroitin-6-sulfate (CS). Lane 5 
is marked to indicate how the plates were cut to measure radioactivity 
in each band. 
and was labeled with both '1H and ass. Hyaluronidase removed 
21- 96 % of the cpm aH associated with that band but did not 
remove the cpm ass. These results indicated that P2 contained 
HA as well as S-GAG constituents. In order to obtain the total 
quantity of'lH incorporated into HA, the 3H cpm present in P2 
that were removed by hyaluronidase treatment were added to 
the 3 H cpm present in Pl. Those data are listed in Table IV: 
For each fraction, M, T , and C, the percentages of cpm 3H 
incorporated into HA increased from NSk, to NSc, to HSc. 
The percentages of cpm aH incorporated into HA was higher 
in medium fractions isolated from HSc fibroblast cutures than 
from NSk fibroblast cultures (p < .15) . The proportion of cpm 
3H associated with HA from the NSc medium fraction was 
intermediate between that of NSk and HSc fibroblasts but not 
statistically different from either. The trypsin ate fractions from 
both the NSc and HSc contained a higher percentage of 3H 
incorporated into HA than did that of NSk. The percent cpm 
JH incorporated into HA from the cellular pool was clearly 
higher in HSc fibroblast cultures than that from either NSk or 
NSc fibroblasts. 
There were significant differences in the distribution of ass_ 
labeled S-GAGs obtained from skin and scar tissue cells. The 
percentage of cpm 3fiS incorporated into CS and. he~aran sul!'ate 
(HS) recovered from the M fraction differed stgmficantly 111 a 
comparison between NSk and HSc (p < .005 for CS) and (p < 
.06 for HS) . The percentage of cpm afis incorporated into DS' 
recovered from the T fractions was greater from NSc than from 
HSc fibrob lasts (p < .06) . Normal skin fibroblasts had signifi-
cantly more "5S incorporated into cell residue DS than did 
either NSc fibrob lasts (p < .02) or HSc fibroblasts (p < .05). 
There was less '15S incorporated into the cell residue HP from 
NSk fibrob lasts than from NSc fibrob lasts (p < 0.20) or from 
HSc fibroblasts (p < .10). There was also less '158 incorporated 
into the cell residue CS in NSk fibrob lasts than either NSc or 
HSc cells (p < .20) . 
DISCUSSION 
Hypertrophic scar tissue contains increased amounts of 
GAGs/PGs. In addition, the collagen from HSc has an altered 
3-dimensional arrangement compared to that found in NSk 
and NSc [8] . Investigators have long considered that there is a 
relationship between the PG content of tissues and the orga-
nization of collagen fibers . A model for the molecular interac-
tion between collagen and HA and PGs presented by Poole and 
colleagues [9] showed how HA and the PGs could influence 3-
dimensional arrangement of the collagen. A connection be-
tween the increased GAGs and collagen postulated by Linares 
and Larson [10] suggested that the increased GAGs protect the 
collagen from the normal remodeling by collagenase, leading to 
the collagen accumulation and excessive scar formation. 
We examined cell lines derived from skin and scars to deter-
mine whether biosynthetic differences could be detected. Here 
we report that fibroblasts derived from HSc incorporated ra-
diolabeled precursors into GAGs in vitro in different propor-
tions from cells derived from normal skin and scars. The other 
comparisons of cell growth, protein synthesis per cell, total 
incorporation of radiolabel into macromolecules, and elution 
profiles of the S-GAGs showed no consistent differences among 
the cell lines from the 3 tissue types. 
In order to minimize the experimental variables, cells were 
obtained from patients 1- 16 years old and only early subpassage 
cells (3-8) were used. As the HSc cell lines taken from different 
anatomic sites gave similar results, it appears that the differ-
ences observed in incorporation of the radiolabels into the 
GAGs were due to differences in the skin and scar fibroblasts 
and not to the anatomic location from which the tissues were 
isolated. An earlier study also showed that there was little 
change in the types of S-GAGs synthesized by human fibro-
blasts with progressive subculture (11]. 
The increased percent incorporated of 35S into CS by HSc 
fibrob lasts reflects the in vivo finding [1]. The greater propor-
tion of aH incorporated into HA isolated from the medium of 
HSc fibroblasts is similar to the report that hypertrophic scar 
tissue contains more HA than normal skin (3]. This finding is 
in contrast to the report that normal skin and hypertrophic 
scar contain more HA than normal scar [1] . 
The distribution of GAGs we observed in the M, T, and C 
fractions, agrees with that reported by others. HA was our most 
abundant labeled GAG constituent [12,13]. In addition, HS 
was relatively more abundant in the trypsinate fraction than 
in either the medium or cellular fractions and CS was the most 
abundant extracellular S-GAG (7,11,12,14,15] . The percent 
cpm 35S recovered from HS listed in Table V was derived from 
3 bands. Most of the radiolabeled material in the presumed HS 
bands (> 70%) was recovered from the slower of the 2 bands 
migrating in the HS-C [6] also called HS-2 region [16]. 
The distribution of '1H-glucosamine labeled GAGs that we 
recovered from the M, T , and C fractions agrees very closely 
with the distribution reported by Sjoberg eta! (17] . This is in 
agreement with other reports [18,19] that the greatest percent-
age of labeled GAGs is recovered from the medium fraction. In 
addition, slightly greater percentage of 3H is recovered from 
the trypsinate pool than from the cellular pool. 
The band referred to as DS' in Table V migrated in the 
region of the HA standard, contained 3H as well as 35S and was 
usually slightly lobular. The cpm 3H from this band were 
reduced by 21- 96% while the cpm 358 were not significantly 
affected by hyaluronidase treatment. The cpm 35S were elimi-
nated by chondroitinase ABC and was reduced by chondroiti-
nase AC. These results suggest that this band contained a 
mixture of HA, probably a low-molecular-weight HA based on 
its elution from CL4B, and a sulfated GAG, possibly a DS/CS 
hybrid which we refer to as DS' . 
DS' has not previously been found in human skin fibroblast 
cultures. A DS comigrating with HA under the electrophoretic 
conditions we used is found in hog kidney, and has a lesser 
degree of iduronation than the DS migrating at t he same place 
as our DS reference [16]. Mourao, Pillai, and Donnelly (20] 
also reported that the CS synthesized in vitro has a hybrid 
structure, explaining why chondroitinase AC could digest at 
least partially what we believe to be DS' , or a DS/CS hybrid. 
The report [21] that there are no differences between the 
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growth rates of NSk and keloid fibroblasts, agrees wit h our 
findings, t hat t he exponent ial growth rates of NSk, NSc, and 
HSc fibroblasts do not differ significantly. 
T he possibili ty that degradation of GAGs/PGs affected t he 
results of t his study cannot be ignored. If that is t he case, it 
seems likely, based on a previous study [19 ], t hat only the cell -
assoc iated pools would be affected to any measurable extent. 
We have examined and found significant differences in the 
incorporation of radio labeled precursers into newly synthesized 
GAGs by fibroblasts from skin and scar in vit ro. Further, we 
have found a presumed 8-GAG which di ffers in electrophoretic 
mobility on cellulose acetate from S-GAGs isolated previously 
from human skin cell cult ures. Other comparisons of protein 
content per cell and cell kinetic parameters between normal 
skin and scar-derived fibroblasts showed no diffe rences. We 
believe that t he diffe rences in the distribut ion of radiolabeled 
precursors into GAGs by hypertrophic scar fibroblasts found 
in vitro may cont ribute to the fo rmation of hypertrophic scars. 
Grateful acknowledgement is expressed to Elizabeth Siebert for 
technical assistance and to Kathy Nee fo r typing t he manuscript. 
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